News Release

West Health comments on Senate action to advance prescription drug reform

Business Announcement

West Health Institute

SAN DIEGO, CA – July 6, 2022 – West Health President Timothy A. Lash issued the following statement on news that Senate Democrats have reportedly agreed to advance prescription drug pricing reform and that legislative text has been submitted to the Senate parliamentarian.

“West Health applauds Senate Democrats for advancing prescription drug pricing reform through a reconciliation package that includes empowering Medicare to negotiate lower drug prices, capping out-of-pocket prescription drug costs and limiting price increases to the rate of inflation.

This is a big step in the right direction and is overwhelmingly popular with the American public. Beneficiaries and their families, and really no person, should have to struggle just to afford their prescription medications. These drug pricing provisions will save lives and taxpayer dollars, and are long overdue. West Health looks forward to its speedy passage and continuing the work to make healthcare more affordable in America.”



About West Health
Solely funded by philanthropists Gary and Mary West, West Health is a family of nonprofit and nonpartisan organizations, including the Gary and Mary West Foundation and Gary and Mary West Health Institute in San Diego and the Gary and Mary West Health Policy Center in Washington, D.C. West Health is dedicated to lowering healthcare costs to enable seniors to successfully age in place with access to high quality, affordable health and support services that preserve and protect their dignity, quality of life and independence. Learn more at and follow @westhealth.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.